Abstract

Hypertriglyceridemic pancreatitis (HTGP) is featured by higher incidence of complications and poor clinical outcomes. Gut microbiota dysbiosis is associated with pancreatic injury in HTGP and the mechanism remains unclear. Here, we observe lower diversity of gut microbiota and absence of beneficial bacteria in HTGP patients. In a fecal microbiota transplantation mouse model, the colonization of gut microbiota from HTGP patients recruits neutrophils and increases neutrophil extracellular traps (NETs) formation that exacerbates pancreatic injury and systemic inflammation. We find that decreased abundance of Bacteroides uniformis in gut microbiota impairs taurine production and increases IL-17 release in colon that triggers NETs formation. Moreover, Bacteroides uniformis or taurine inhibits the activation of NF-κB and IL-17 signaling pathways in neutrophils which harness NETs and alleviate pancreatic injury. Our findings establish roles of endogenous Bacteroides uniformis-derived metabolic and inflammatory products on suppressing NETs release, which provides potential insights of ameliorating HTGP through gut microbiota modulation.

Given the association of gut microbiota dysbiosis with hypertriglyceridemic pancreatitis (HTGP), authors assess the gut microbial diversity of patients with HTGP, and provide immunological insight utilising a murine model.

Details

Title
Gut microbiota aggravates neutrophil extracellular traps-induced pancreatic injury in hypertriglyceridemic pancreatitis
Author
Li, Guanqun 1 ; Liu, Liwei 1 ; Lu, Tianqi 1 ; Sui, Yuhang 1 ; Zhang, Can 1 ; Wang, Yongwei 2 ; Zhang, Tao 2 ; Xie, Yu 2 ; Xiao, Peng 2 ; Zhao, Zhongjie 2 ; Cheng, Chundong 2 ; Hu, Jisheng 1 ; Chen, Hongze 1 ; Xue, Dongbo 2 ; Chen, Hua 2 ; Wang, Gang 2 ; Kong, Rui 1 ; Tan, Hongtao 2 ; Bai, Xuewei 2 ; Li, Zhibo 2 ; McAllister, Florencia 3   VIAFID ORCID Logo  ; Li, Le 1   VIAFID ORCID Logo  ; Sun, Bei 1   VIAFID ORCID Logo 

 The First Affiliated Hospital of Harbin Medical University, Department of Pancreatic and Biliary Surgery, Harbin, China (GRID:grid.412596.d) (ISNI:0000 0004 1797 9737); Ministry of Education, Key Laboratory of Hepatosplenic Surgery, Harbin, China (GRID:grid.419897.a) (ISNI:0000 0004 0369 313X) 
 The First Affiliated Hospital of Harbin Medical University, Department of Pancreatic and Biliary Surgery, Harbin, China (GRID:grid.412596.d) (ISNI:0000 0004 1797 9737) 
 The University of Texas MD Anderson Cancer Center, Department of Clinical Cancer Prevention, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776); The University of Texas MD Anderson Cancer Center, Department of Gastrointestinal Medical Oncology, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776); The University of Texas MD Anderson Cancer Center, Clinical Cancer Genetics Program, Houston, USA (GRID:grid.240145.6) (ISNI:0000 0001 2291 4776) 
Pages
6179
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2872534992
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.